Comments
Pharma major Dr Reddy’s Laboratories has launched Ropinirole Hydrochloride XR (Extended-Release) tablets in the US market.
The tablets are a bioequivalent generic version of Requip XL tablets of SmithKline Beecham Ltd which are indicated for the treatment of Parkinson’s disease.
The Requip XL brand had US sales of approximately $58 million for the most recent twelve months ending March 2012, according to IMS Health, the company said in a release on Thursday.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.